The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Requests for restoration and notices of objection, notices of objection to Court, notices of objection to appelate court ex NL Patent Law 1995 in respect of which a decision has been taken. Opposition(s) decisions ex European Patent Convention
3
Bulletin Heading:
MED
Journal edition number:
2015/12
Publication date:
18/03/2015
Description:
Other communications
4
Bulletin Heading:
VB1
Journal edition number:
2011/31
Publication date:
03/08/2011
Description:
Requests for restoration and notices of objection, notices of objection to Court, notices of objection to appelate court ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention
5
Bulletin Heading:
EP3
Journal edition number:
2010/40
Publication date:
24/11/2010
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995
6
Bulletin Heading:
EP2
Journal edition number:
2010/32
Publication date:
29/09/2010
Description:
European patents granted for the Netherlands
European Patent Bulletin
1
Issue number:
201803
Publication date:
17/01/2018
Description:
Opposition rejected; Patent maintained as granted
2
Issue number:
201130
Publication date:
27/07/2011
Description:
Opposition procedure started
3
Issue number:
201038
Publication date:
22/09/2010
Description:
Grant (B1)
Deed
Registration Summons/Subpoena
Change Kind/ Decision Type:
For Invalidity declaration
Deed Number:
023344-A023344-1
Date Registered:
03/03/2015
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
De Brauw Blackstone Westbroek
Journal Edition Number:
Text:
Indiening dagvaarding nietigverklaring 3 maart 2015 door De Brauw Blackstone Westbroek te Amsterdam. Op verzoek van Merck Sharp & Dohme B.V. te Haarlem. Octrooihouders zijn Tasuku Honjo te Kyoto (JP) en Ono Pharmaceutical Co., Ltd te Osaka (JP) Zie verder de akte.